OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Increasing Access to Effective Systemic Treatments in Patients with Moderate-to-Severe Psoriasis: Narrative Review
Giampiero Girolomoni, L. Savage, Paolo Gisondi, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 10, pp. 2171-2185
Open Access | Times Cited: 7
Giampiero Girolomoni, L. Savage, Paolo Gisondi, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 10, pp. 2171-2185
Open Access | Times Cited: 7
Showing 7 citing articles:
Plant-Based Foods for Chronic Skin Diseases: A Focus on the Mediterranean Diet
Giuseppe Annunziata, Ludovica Verde, Alexander Zink, et al.
Current Nutrition Reports (2025) Vol. 14, Iss. 1
Open Access
Giuseppe Annunziata, Ludovica Verde, Alexander Zink, et al.
Current Nutrition Reports (2025) Vol. 14, Iss. 1
Open Access
A Randomised, Double-Blind Trial to Compare the Efficacy, Safety, and Immunogenicity of the Biosimilar Ustekinumab FYB202 with Reference Ustekinumab in Patients with Moderate-to-Severe Plaque Psoriasis
Kim Papp, Sigrid Balser, Katrin Nopora, et al.
Advances in Therapy (2025)
Open Access
Kim Papp, Sigrid Balser, Katrin Nopora, et al.
Advances in Therapy (2025)
Open Access
Choosing the right biologic treatment for moderate-to-severe plaque psoriasis: the impact of comorbidities
Laura Mateu Arrom, L. Puig
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 4, pp. 363-379
Closed Access | Times Cited: 2
Laura Mateu Arrom, L. Puig
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 4, pp. 363-379
Closed Access | Times Cited: 2
Adalimumab in the management of psoriasis and psoriatic arthritis: Results from a Delphi investigation
Marco Matucci‐Cerinic, Francesco Ciccia, Rosario Foti, et al.
Rheumatology and Immunology Research (2024) Vol. 5, Iss. 1, pp. 49-56
Open Access | Times Cited: 1
Marco Matucci‐Cerinic, Francesco Ciccia, Rosario Foti, et al.
Rheumatology and Immunology Research (2024) Vol. 5, Iss. 1, pp. 49-56
Open Access | Times Cited: 1
NLRP3 (rs10754558) gene polymorphism and tumor necrosis factor alpha as predictors for disease activity and response to methotrexate and adalimumab in psoriasis
Fatma Z Kamel, Heba Allah Mohamed Hoseiny, Aya A El Shahawy, et al.
BMC Immunology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Fatma Z Kamel, Heba Allah Mohamed Hoseiny, Aya A El Shahawy, et al.
BMC Immunology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
A review of biosimilars in psoriasis: impacts on efficacy, safety, access, and a first-hand look at biosimilar cost savings within the department of veterans affairs
Rebecca R Reese, Shiva Ram Nanavath, Jennifer L. Martin, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 1
Rebecca R Reese, Shiva Ram Nanavath, Jennifer L. Martin, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 1
A real-world retrospective study on biologics utilization in patients with psoriasis in Greece during the period 2015–2020
Elizabeth Lazaridou, Georgia Kourlaba, Dionysia Lampropoulou, et al.
Archives of Dermatological Research (2024) Vol. 316, Iss. 7
Closed Access
Elizabeth Lazaridou, Georgia Kourlaba, Dionysia Lampropoulou, et al.
Archives of Dermatological Research (2024) Vol. 316, Iss. 7
Closed Access
